ABT - ABBOTT LABORATORIES

113.1
-0.510   -0.451%

Share volume: 4,603,868
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.72%

PREVIOUS CLOSE
CHG
CHG%
$113.61
-0.51
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
58%
Profitability 59%
Dept financing 32%
Liquidity 75%
Performance 58%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-0.89%
1 Month
3.69%
3 Months
-9.58%
6 Months
-14.92%
1 Year
-17.87%
2 Year
-4.54%
Key data
Stock price
$113.10
P/E Ratio 
33.23
DAY RANGE
$112.03 - $113.95
EPS 
$3.73
52 WEEK RANGE
$105.27 - $139.15
52 WEEK CHANGE
-$16.27
MARKET CAP 
216.765 B
YIELD 
1.89%
SHARES OUTSTANDING 
1.738 B
DIVIDEND
$0.59
EX-DIVIDEND DATE
07-15-2025
NEXT EARNINGS DATE
07-17-2025
BETA 
0.18
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$8,099,160
AVERAGE 30 VOLUME 
$9,301,671
Company detail
CEO: Robert B. Ford
Region: US
Website: abbott.com
Employees: 115,000
IPO year: 1983
Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Abbott Laboratories discovers, develops, manufactures, and sells health care products. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases.

Recent news